Quaker Partners

Active

Website LinkedIn X

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 16, 2021	Rapid Micro Biosystems	$81.0M Other Equity	D1 Capital Partners	Adage Capital Management, Ally Bridge Group, Asahi Kasei Medical, Bain Capital Life Sciences, BlackRock, CaaS Capital Management, Endeavour Vision, Longitude Capital, Sunley House Capital, T. Rowe Price Associates, Xeraya Capital
May 29, 2019	Intact Vascular	$25.0M Other Equity	Justin Klein	H.I.G. BioHealth Partners, New Enterprise Associates
May 29, 2019	Vesper Medical	$37.0M Other Equity	Justin Klein	New Enterprise Associates
May 11, 2018	Vesper Medical	$10.5M Series A	Justin Klein, Quaker Partners	—
May 2, 2018	Rapid Micro Biosystems	$60.0M Other Equity	Jeff Schwartz, Fares Zahir	Asahi Kasei Medical, Longitude Capital, TVM Capital
Apr 1, 2018	Intact Vascular	$20.0M Series C	—	Vensana Capital, H.I.G. BioHealth Partners, Justin Klein
Jan 1, 2017	Intact Vascular	$7.0M Series B	—	Vensana Capital, H.I.G. BioHealth Partners, Justin Klein
May 1, 2015	Intact Vascular	$39.0M Series B	Justin Klein	Vensana Capital, H.I.G. BioHealth Partners
Apr 1, 2015	Rapid Micro Biosystems	$25.0M Series C	—	Apollo Health Ventures, Shawn Lu, Kleiner Perkins, Longitude Capital, Richard King Mellon Foundation, Fred Cohen, TVM Capital
May 1, 2014	Tarsa Therapeutics	$7.0M Series B	—	Foresite Capital, MVM Partners, Novo Holdings
Dec 23, 2013	Intact Vascular	$4.7M Other Equity	—	H.I.G. BioHealth Partners
Jun 1, 2013	Rapid Micro Biosystems	$33.0M Series B	David Hirsch, Mark Braganza	Apollo Health Ventures, Kleiner Perkins, TVM Capital
Dec 1, 2012	Regado Biosciences	$51.0M Series E	RusnanoMedInvest	Domain Associates, Aurora Funds, Baxter Ventures, Caxton Advantage
Sep 5, 2012	Intact Vascular	$15.5M Series A	Aaron Davidson, Wes Kaupinen	—
Mar 1, 2012	Tarsa Therapeutics	$28.0M Series B	Foresite Capital	MVM Partners, Novo Holdings
Dec 30, 2011	Celator Pharmaceuticals	$2.6M Other Equity	—	Domain Associates, GrowthWorks, The Leukemia & Lymphoma Society, Ventures West
Jun 27, 2011	NovaSom	$35.0M Series D	James A. Datin	TPG
May 1, 2011	Neuronetics	$30.0M Series E	Kevin Bitterman	Access Biotechnology, Atlas Venture, Borealis Ventures, Flagship Ventures, GE Ventures, InterWest, SR One, Vivo Capital, Wildcat Ventures, Timothy A. Springer, InterWest Partners, Investor Growth Capital, New Leaf Venture Partners, ONSET Ventures, Three Arch Partners
Jan 1, 2011	RainDance Technologies	$38.0M Series D	Mohr Davidow Ventures, P. Sherrill Neff	TCV, Wildcat Ventures, Joanna Rees, Jeff Samberg, Alloy Ventures
Aug 1, 2010	Celator Pharmaceuticals	$20.0M Series D	Alex Zisson	Domain Associates, BDC Capital, GrowthWorks, TL Ventures, Ventures West
Jun 18, 2010	Precision Therapeutics	$35.0M Other Equity	Jeff Crisan	Adams Capital Management, Birchmere Ventures, Longitude Capital, TVM Capital
May 5, 2010	TearScience	$44.5M Series C	—	De Novo Ventures, General Catalyst, Investor Growth Capital, Spray Venture Partners
Dec 1, 2009	Regado Biosciences	$40.0M Series D	—	Domain Associates, Aurora Funds, Caxton Advantage
Oct 21, 2009	Tarsa Therapeutics	$24.0M Series A	—	MVM Partners, Martin Edwards, Matt Rieke, MD, MBA
Aug 2, 2007	Celator Pharmaceuticals	$10.0M Other Equity	—	BDC Capital, Domain Associates, GrowthWorks, Hearthstone Investments, TL Ventures, Ventures West